Immune cell trafficking controls leukocyte migration, tissue infiltration, and responses to inflammatory or tumor-associated signals. GPCRs, especially chemokine receptors such as CCR/CXCR family members and complement receptors such as C5AR1 and C5AR2, are key regulators of this process. These targets are widely used in immunology, oncology, inflammation, and antibody discovery research.
C-X-C chemokine receptor type 4 (CXCR4)
- Aliases: CD184, Fusin, LESTR
- Indication: Hematologic malignancies; tumor metastasis
Atypical chemokine receptor 3 (ACKR3)
- Aliases: CXCR7, RDC1
- Indication: cancer progression; angiogenesis
C-C chemokine receptor type 8 (CCR8)
- Aliases: CD198, CMKBR8
- Indication: Treg-targeted solid tumor immunotherapy
C-C motif chemokine receptor 1 (CCR1)
- Aliases: CD191, CMKBR1
- Indication: Autoimmune and Inflammatory Diseases
C-C chemokine receptor type 2 (CCR2)
- Aliases: CD192, MCP-1R, CKR2
- Indication: Inflammatory disease; fibrosis
C-X-C chemokine receptor type 3 (CXCR3)
- Aliases: CD183, GPR9
- Indication: Autoimmune disease; T cell-mediated inflammation
Complement C5a receptor 1 (C5AR1)
- Aliases: C5aR, CD88
- Indication: Complement-mediated inflammation
Complement C5a receptor 2 (C5AR2)
- Aliases: C5L2, GPR77
- Indication: Sepsis; inflammatory disease
